Skip to main content

Change in Cardiorespiratory Fitness Linked to Prostate Cancer Incidence

Medically reviewed by Judith Stewart, BPharm. Last updated on Jan 31, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Jan. 31, 2024 -- Change in cardiorespiratory fitness (CRF) is inversely associated with the risk for prostate cancer incidence, but not mortality, according to a study published online Jan. 30 in the British Journal of Sports Medicine.

Kate A. Bolam, Ph.D., from the Swedish School of Sport and Health Sciences GIH in Stockholm, and colleagues conducted a prospective study to examine the associations between changes in CRF in adulthood and prostate cancer incidence and mortality. The study included men who completed an occupational health profile assessment, including at least two valid submaximal CRF tests.

The researchers found that 592 of the 57,652 men (1 percent) were diagnosed with prostate cancer during a mean follow-up of 6.7 years, and 0.08 percent died with prostate cancer as the primary cause of death. In the fully adjusted model, there was an association seen for an increase in absolute CRF with a reduced risk for prostate cancer incidence (hazard ratio, 0.98), but not mortality. In the fully adjusted model, when participants were categorized as having increased, stable, or decreased CRF (+3, ±3, and −3 percent, respectively), the risk for prostate cancer was reduced for those with increased versus decreased fitness (hazard ratio, 0.65).

"The findings of this study provide further clarity on the associations between CRF and cancer incidence in an area of research with conflicting results," the authors write. "The results of this study highlight the important role of supporting the general public to increase their CRF or aim to reach moderate fitness levels."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Black Patients More Likely to Experience MACE After ADT for Prostate Cancer

THURSDAY, June 20, 2024 -- Black patients are more likely to experience adverse cardiovascular outcomes after systemic androgen deprivation therapy (ADT) for prostate cancer...

Higher County-Level Prostate Cancer Screening Tied to Better Outcomes

FRIDAY, June 7, 2024 -- Higher county-level prevalence of prostate-specific antigen (PSA) screening is associated with lower odds of advanced disease, all-cause mortality, and...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.